Late September 2016, leading glycosaminoglycan specialists convened to discuss the future of Heparin at the Institute Ronzoni Symposium, and we had the opportunity to talk to some of them. At this interview, Mr. Shriver talks about the recent efforts to take molecular level characterization techniques and apply them to the control of heparin.
